| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a112fa5dd8cc717ee8bdb5e4004d0b0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 |
| filingDate |
2001-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2b1a3cbe9912251a990ca1e4412b94d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaf88755d46e664f643677bf57f1cff7 |
| publicationDate |
2001-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0178729-A1 |
| titleOfInvention |
Method of dopamine inhibition using l-threo-methylphenidate |
| abstract |
This invention provides methods of effecting dopamine inhibition in a mammal by administering to the mammal l-threo-MPH which is substantially free from d-threo-MPH. Also provided by the invention are methods of inhibiting the effects of a stimulant in a mammal by administering to the mammal l-threo-MPH which is substantially free from d-threo-MPH. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0217919-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0217919-A3 |
| priorityDate |
2000-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |